Showing 351-360 of 2392 results for "".
News
https://practicalneurology.com/columns/practice-management/news/30596/Movement Disorders Focus: Harnessing Existing Drugs to Slow Progression of Parkinson's Disease: The STEADY-PDIII Trial of Isradipine
https://practicalneurology.com/diseases-diagnoses/movement-disorders/harnessing-existing-drugs-to-slow-progression-of-parkinsons-disease-the-steady-pdiii-trial-of-isradipine/30654/How Biomarkers are Changing Knowledge and Management of Alzheimer's Disease
https://practicalneurology.com/columns/practice-management/how-biomarkers-are-changing-knowledge-and-management-of-alzheimers-disease/30807/Researchers and clinicians weigh in on the progress and potential of AD biomarker research.Marijuana Use and Ischemic Stroke
https://practicalneurology.com/columns/practice-management/marijuana-use-and-ischemic-stroke/30705/Endovascular Treatment for Acute Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/endovascular-treatment-for-acute-ischemic-stroke/30198/The evidence shines a light on the need for stroke education for both clinicians and the public.Physical Therapy for Low-Back Pain: How the Neurologist Can Facilitate Optimal Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/PN0609_07-php/30911/Despite the frequency with which they order it, neurologists typically don't have formal training on the specifics of physical therapy. Here's how to make good referrals.Inclusive Research for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/inclusive-research-for-multiple-sclerosis/31755/Inclusive research improves quality of scientific data, facilitates discovery of safety and efficacy, and assists in identifying population-specific differences.Movement Disorders Moment: Environmental and Biologic Risk and Protective Factors Associated with Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-momentbrenvironmental-and-biologic-risk-and-protective-factors-associated-with-parkinson-disease/32120/This review provides a concise summary of the evidence for environmental and biologic risk and protective factors for Parkinson disease.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Bruton Tyrosine Kinase Inhibition in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/bruton-tyrosine-kinase-inhibition-in-multiple-sclerosis/31872/The missing link for treatment optimization?